Prognostic factors for overall survival in paediatric patients with Ewing sarcoma of bone treated according to multidisciplinary protocol

Clinical and Translational Oncology

Volumn 14, Issue 4, 2012, Pages 294-301

  Guerra, José Luis López ^a,b   Márquez Vega, Catalina ^b   Ramírez Villar, Gema Lucía ^b   Cabrera, Patricia ^b   Ordóñez, Rafael ^b   Praena Fernández, Juan Manuel ^b   Ortiz, María José ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Ewing sarcoma; Paediatric oncology; Prognostic factors

Indexed keywords

BLEOMYCIN; BUSULFAN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; LACTATE DEHYDROGENASE; MELPHALAN; METHOTREXATE; VINCRISTINE;

ADOLESCENT; AGE; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW TRANSPLANTATION; BONE METASTASIS; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVOR; CLINICAL PROTOCOL; DISEASE DURATION; DISEASE FREE SURVIVAL; DISTANT METASTASIS; EWING SARCOMA; FEMALE; GENDER; HUMAN; INDUCTION CHEMOTHERAPY; LACTATE DEHYDROGENASE BLOOD LEVEL; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OSTEOSARCOMA; OVERALL SURVIVAL; PROGNOSIS; RETROSPECTIVE STUDY; TREATMENT RESPONSE; TUMOR LOCALIZATION; TUMOR VOLUME;

ADOLESCENT; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MEDICAL ONCOLOGY; MULTIVARIATE ANALYSIS; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; SARCOMA, EWING; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84860784049     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-012-0798-y     Document Type: Article

References (32)

1. de Alava E (2007) Molecular pathology in sarcomas. Clin Transl Oncol 9:130-144
2. Rodriguez-Galindo C, Liu T, Krasin MJ et al (2007) Analysis of prognostic factors in ewing sarcoma family of tumors: review of St. Jude Children's Research Hospital studies. Cancer 110:375-384 (Pubitemid 47121899)
3. Bernstein M, Kovar H, Paulussen M et al (2005) Ewing sarcoma family of tumors: Ewing sarcoma of bone and soft tissue and the peripheral primitive neuroectodermal tumors. In: Pizzo P, Poplack D (eds) Principles and practice of pediatric oncology, 5th edn. Lippincott Williams and Wilkins, Philadelphia, pp 1002-1032
4. Peris-Bonet R (2008) Incidencia y supervivencia del cancer infantil. Rev Esp Pediatr 64:342-356
5. Craft AW, Paulussen M, Douglas C et al (2000) EICESS 92: early results of an international Ewings tumour study. Med Pediatr Oncol 35:191
6. Grier HE, Krailo MD, Tarbell NJ et al (2003) Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med 348:694-701 (Pubitemid 36237038)
7. Rodriguez-Galindo C, Spunt SL, Pappo AS (2003) Treatment of Ewing sarcoma family of tumors: current status and outlook for the future. Med Pediatr Oncol 40:276-287 (Pubitemid 36397630)
8. Cotterill SJ, Ahrens S, Paulussen M et al (2000) Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group. J Clin Oncol 18:3108-3114
9. Miser JS, Goldsby RE, Chen Z et al (2007) Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: evaluation of increasing the dose intensity of chemotherapy-a report from the Children's Oncology Group. Pediatr Blood Cancer 49:894-900 (Pubitemid 350022441)
10. American Joint Committee on Cancer (2002) Bone. In: Greene FL, Page DL, Fleming ID et al (eds) AJCC cancer staging manual. SpringerVerlag, New York, NY, pp 213-219
11. Rosen G, Caparros B, Nirenberg A et al (1981) Ewing's sarcoma: ten-year experience with adjuvant chemotherapy. Cancer 47:2204-2213 (Pubitemid 11098590)
12. Kushner BH, Meyers PA, Gerald WL et al (1995) Very-high-dose short-term chemotherapy for poorrisk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults. J Clin Oncol 13:2796-2804
13. Donaldson SS, Torrey M, Link MP et al (1998) A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: end results of POG #8346. Pediatric Oncology Group. Int J Radiat Oncol Biol Phys 42:125-135 (Pubitemid 28435605)
14. WHO (1979) Handbook for reporting results of cancer treatment. World Health Organization, Geneva, Offset Publication No. 48
15. Therasse P, Arbuck SG, Eisenhauer EA et al (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205-216
16. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481
17. Bacci G, Ferrari S, Mercuri M et al (2003) Multimodal therapy for the treatment of nonmetastatic Ewing sarcoma of pelvis. J Pediatr Hematol Oncol 25:118-124 (Pubitemid 36194038)
18. Rodriguez-Galindo C, Navid F, Liu T et al (2008) Prognostic factors for local and distant control in Ewing sarcoma family of tumors. Ann Oncol 19:814-820 (Pubitemid 351461056)
19. Peng RJ, Sun XF, Xiang XJ et al (2009) Efficacy and survival of 92 cases of Ewing's sarcoma family of tumor initially treated with multidisciplinary therapy. Ai Zheng 28:1304-1309
20. Yonemori K, Yamaguchi U, Kaneko M et al (2008) Prediction of response and prognostic factors for Ewing family of tumors in a low incidence population. J Cancer Res Clin Oncol 34:389-395 (Pubitemid 351170061)
21. Jurgens H, Exner U, Gadner H et al (1988) Multidisciplinary treatment of primary Ewing's sarcoma of bone. A 6-year experience of a European Cooperative Trial. Cancer 61:23-32 (Pubitemid 18023106)
22. Paulussen M, Ahrens S, Dunst J et al (2001) Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86 J Clin Oncol 19:1818-1829 (Pubitemid 32230885)
23. Bacci G, Ferrari S, Longhi A et al (2003) Therapy and survival after recurrence of Ewing's tumors: the Rizzoli experience in 195 patients treated with adjuvant and neoadjuvant chemotherapy from 1979 to 1997. Ann Oncol 14:1654-1659 (Pubitemid 37455815)
24. Rodriguez-Galindo C, Billups CA, Kun LE et al (2002) Survival after recurrence of Ewing tumors: the St Jude Children's Research Hospital experience, 1979-1999. Cancer 94:561-569 (Pubitemid 34081388)
25. Bacci G, Forni C, Longhi A et al (2004) Longterm outcome for patients with non-metastatic Ewing's sarcoma treated with adjuvant and neoadjuvant chemotherapies. 402 patients treated at Rizzoli between 1972 and 1992. Eur J Cancer 40:73-83 (Pubitemid 37542320)
26. Lee J, Hoang BH, Ziogas A, Zell JA (2010) Analysis of prognostic factors in Ewing sarcoma using a population-based cancer registry. Cancer 116:1964-1973
27. Shafat I, Ben-Arush MW, Issakov J et al (2010) Preclinical and clinical significance of heparanase in Ewing's sarcoma. J Cell Mol Med 15:1857-1864
28. Sari N, Togral G, Cetindag MF et al (2010) Treatment results of the Ewing sarcoma of bone and prognostic factors. Pediatr Blood Cancer 54:19-24
29. Leavey PJ, Mascarenhas L, Marina N et al (2008) Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multimodality therapy: a report from the Children's Oncology Group. Pediatr Blood Cancer 51:334-338
30. Miser JS, Kinsella TJ, Triche TJ et al (1987) Ifosfamide with mesna uroprotection and etoposide: an effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults. J Clin Oncol 5:1191-1198 (Pubitemid 18045304)
31. Jurgens H, Exner U, Kuhl J et al (1989) High-dose ifosfamide with mesna uroprotection in Ewing's sarcoma. Cancer Chemother Pharmacol 24[Suppl 1]:S40-44 (Pubitemid 19197363)
32. Pinkerton CR, Rogers H, James C et al (1985) A phase II study of ifosfamide in children with recurrent solid tumours. Cancer Chemother Pharmacol 15:258-262 (Pubitemid 15240975)